Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
AGIOS PHARMACEUTICALS, INC. | Chief Commercial Officer | Restricted stock units | 17K | $593K | $34.89 | Mar 1, 2024 | Direct |
AGIOS PHARMACEUTICALS, INC. | Chief Commercial Officer | Common stock | 13.2K | $286K | $21.64 | Jan 24, 2024 | Direct |
AGIOS PHARMACEUTICALS, INC. | Chief Commercial Officer | Stock options (right to buy) | 60K | Mar 1, 2024 | Direct | ||
AGIOS PHARMACEUTICALS, INC. | Chief Commercial Officer | Performance share units | 0 | $21.64 | Jan 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AGIO | AGIOS PHARMACEUTICALS, INC. | Mar 1, 2024 | 2 | $0 | 4 | Mar 5, 2024 | Chief Commercial Officer |
AGIO | AGIOS PHARMACEUTICALS, INC. | Jan 20, 2024 | 3 | -$35K | 4 | Jan 24, 2024 | Chief Commercial Officer |
AGIO | AGIOS PHARMACEUTICALS, INC. | Jan 3, 2024 | 3 | -$64.8K | 4 | Jan 5, 2024 | Chief Commercial Officer |
AGIO | AGIOS PHARMACEUTICALS, INC. | Jun 28, 2023 | 3 | -$45.9K | 4 | Jun 30, 2023 | Chief Commercial Officer |
AGIO | AGIOS PHARMACEUTICALS, INC. | Jan 3, 2023 | 2 | $0 | 4 | Jan 5, 2023 | Chief Commercial Officer |
AGIO | AGIOS PHARMACEUTICALS, INC. | Jan 3, 2023 | 0 | $0 | 3 | Jan 5, 2023 | Chief Commercial Officer |